On August 26, Somnigroup International (NYSE:SGI) completed its combination with Leggett & Platt, folding a components manufacturer with nearly 140 years of history into a bedding company that already owns some of the best-known names in sleep. The all-stock deal, first announced April 13 and valued at roughly $2.3 billion based on Somnigroup’s closing price the day before, gives Somnigroup direct control over a piece of its own supply chain. Three weeks earlier, on August 6, Somnigroup had already shown a core business growing earnings even as sales slipped.
Buying The Business That Feeds It
The logic behind the deal shows up in the numbers right away. Somnigroup didn’t just absorb Leggett & Platt; it used the deal to make its balance sheet healthier, with net leverage falling to roughly 2.8 times adjusted EBITDA at close, down about 0.2 times, and management targeting the middle of its 2.0 to 3.0 times range by year-end. Management also raised its own bar on what the deal is worth, lifting the annual run-rate synergy target to $75 million from an initial $50 million estimate. That’s a meaningful upward revision, suggesting the two companies are finding more overlap to cut than they expected going in. The combined company now runs more than 170 manufacturing facilities across 37 countries with over 36,000 employees, giving Somnigroup engineering and component capabilities it previously had to buy from outside suppliers.
None of this required the core business to slow down while it happened. Three weeks before the deal closed, Somnigroup reported second-quarter 2026 results showing adjusted earnings per share up 9.4% to $0.58 even as total net sales slipped 3.0% to $1,823.5 million. Gross margin expanded to 44.8% from 44.0% a year earlier, and the company generated a record $236 million in operating cash flow for the quarter. Leverage across the whole business was already declining before Leggett & Platt closed, down to 2.99 times adjusted EBITDA from 3.56 times a year earlier. On the strength of that, Somnigroup raised its full-year adjusted EPS guidance to a range of $2.85 to $3.15, roughly 11% above 2025 at the midpoint.
Where The Growth Isn’t Showing Up
Look past the adjusted figures and the top line tells a tougher story. Total net sales fell 3.0% in the quarter, and Mattress Firm, the company’s largest segment, saw sales drop 2.8% to $922.2 million as the company closed stores. Mattress Firm’s adjusted gross margin also slid 240 basis points to 33.3%, which the company tied to product mix, financing costs on customer purchases, and deleverage from lower sales volume. Adjusted operating income for the whole company actually fell 3.5% in the quarter even as adjusted net income and EPS rose, a gap worth noticing. Internationally, sales grew just 1.3% on a constant currency basis while operating margin compressed 120 basis points on commodity cost inflation, pushing Somnigroup to raise prices after the quarter closed just to keep pace.
The Leggett & Platt deal adds its own drag to reported results, even where it won’t touch the adjusted numbers investors tend to focus on. Somnigroup expects about $50 million a year in non-cash expense from marking the acquired business up to fair value, mostly hitting cost of goods sold, plus another $10 million in non-cash interest expense from revaluing Leggett & Platt’s bonds. Somnigroup also flagged tariffs, trade policy changes, and geopolitical uncertainty, including the wars in Ukraine and the Middle East, as risks to its own guidance. None of that is unique to this deal, but a components manufacturer running 170-plus factories across 37 countries has more moving parts exposed to that uncertainty than a pure retailer would.
What The Market Is Pricing In
Hedge fund ownership of Somnigroup climbed from 63 funds to 74 in the most recent quarter. That’s a rising count, which typically reads as institutions accumulating rather than trimming their positions. Short interest sits at 8.94% of the float, a level that points to a genuine bear camp rather than routine hedging. The stock trades at a forward P/E of 25.77, as of September 17, a multiple that already assumes real earnings growth ahead rather than a bargain price. Rising fund ownership against that much short interest and an already full multiple leaves plenty of room for the two camps to disagree.
The Tension Now Facing Somnigroup
Somnigroup closed the biggest deal in its history while its core mattress business kept growing earnings on a shrinking top line, a combination that cuts both ways. For the bull case, the synergy target has already been raised once, and Leggett & Platt secures a supply chain Somnigroup was previously buying on the open market. For the bear case, both segments show margin pressure that predates this deal, and reported earnings will carry new non-cash charges for years from the fair value markup. The next test comes soon, with Somnigroup hosting a business update call on September 2 to detail how those synergies get realized.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Hedge Fund Resource Center